nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—ACE—polycystic ovary syndrome	0.724	1	CbGaD
Lisinopril—ACE2—Metabolism of Angiotensinogen to Angiotensins—CPB2—polycystic ovary syndrome	0.0212	0.189	CbGpPWpGaD
Lisinopril—ACE—tunica intima—polycystic ovary syndrome	0.0172	0.243	CbGeAlD
Lisinopril—ACE—Metabolism of Angiotensinogen to Angiotensins—CPB2—polycystic ovary syndrome	0.00947	0.0846	CbGpPWpGaD
Lisinopril—ACE—urine—polycystic ovary syndrome	0.00848	0.119	CbGeAlD
Lisinopril—ACE2—Metabolism of Angiotensinogen to Angiotensins—ACE—polycystic ovary syndrome	0.0076	0.0679	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—CGB5—polycystic ovary syndrome	0.00735	0.0657	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—ACE—polycystic ovary syndrome	0.00724	0.0647	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—CPB2—polycystic ovary syndrome	0.00557	0.0498	CbGpPWpGaD
Lisinopril—ACE2—adipose tissue—polycystic ovary syndrome	0.00553	0.0778	CbGeAlD
Lisinopril—ACE2—female gonad—polycystic ovary syndrome	0.00463	0.0651	CbGeAlD
Lisinopril—ACE2—vagina—polycystic ovary syndrome	0.0046	0.0647	CbGeAlD
Lisinopril—ACE2—endocrine gland—polycystic ovary syndrome	0.0043	0.0605	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—INHBB—polycystic ovary syndrome	0.00422	0.0377	CbGpPWpGaD
Lisinopril—Appetite absent—Metformin—polycystic ovary syndrome	0.00413	0.0491	CcSEcCtD
Lisinopril—Azotaemia—Metformin—polycystic ovary syndrome	0.00385	0.0458	CcSEcCtD
Lisinopril—ACE—Peptide hormone metabolism—CGB5—polycystic ovary syndrome	0.00328	0.0293	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—LHB—polycystic ovary syndrome	0.00312	0.0279	CbGpPWpGaD
Lisinopril—Heartburn—Metformin—polycystic ovary syndrome	0.00298	0.0355	CcSEcCtD
Lisinopril—SLC15A1—endometrium—polycystic ovary syndrome	0.0028	0.0394	CbGeAlD
Lisinopril—ACE—embryo—polycystic ovary syndrome	0.00274	0.0386	CbGeAlD
Lisinopril—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00253	0.0301	CcSEcCtD
Lisinopril—ACE—Peptide hormone metabolism—CPB2—polycystic ovary syndrome	0.00249	0.0222	CbGpPWpGaD
Lisinopril—Accidental injury—Metformin—polycystic ovary syndrome	0.00232	0.0276	CcSEcCtD
Lisinopril—Chest discomfort—Metformin—polycystic ovary syndrome	0.00232	0.0276	CcSEcCtD
Lisinopril—SLC15A1—vagina—polycystic ovary syndrome	0.0021	0.0295	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—GHRL—polycystic ovary syndrome	0.00206	0.0184	CbGpPWpGaD
Lisinopril—ACE—endometrium—polycystic ovary syndrome	0.00201	0.0282	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—ACE—polycystic ovary syndrome	0.002	0.0178	CbGpPWpGaD
Lisinopril—SLC15A1—endocrine gland—polycystic ovary syndrome	0.00196	0.0276	CbGeAlD
Lisinopril—Neuropathy—Metformin—polycystic ovary syndrome	0.00193	0.0229	CcSEcCtD
Lisinopril—ACE2—Peptide hormone metabolism—TCF7L2—polycystic ovary syndrome	0.00192	0.0171	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—INHBB—polycystic ovary syndrome	0.00189	0.0168	CbGpPWpGaD
Lisinopril—Lightheadedness—Metformin—polycystic ovary syndrome	0.00184	0.0219	CcSEcCtD
Lisinopril—ACE—pituitary gland—polycystic ovary syndrome	0.00182	0.0255	CbGeAlD
Lisinopril—ACE—adipose tissue—polycystic ovary syndrome	0.00181	0.0254	CbGeAlD
Lisinopril—Nasal congestion—Metformin—polycystic ovary syndrome	0.00164	0.0195	CcSEcCtD
Lisinopril—ACE—adrenal gland—polycystic ovary syndrome	0.00162	0.0228	CbGeAlD
Lisinopril—Injury—Metformin—polycystic ovary syndrome	0.00162	0.0193	CcSEcCtD
Lisinopril—Renal impairment—Metformin—polycystic ovary syndrome	0.00157	0.0186	CcSEcCtD
Lisinopril—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00153	0.0182	CcSEcCtD
Lisinopril—ACE—female gonad—polycystic ovary syndrome	0.00151	0.0213	CbGeAlD
Lisinopril—Pain in extremity—Metformin—polycystic ovary syndrome	0.00149	0.0177	CcSEcCtD
Lisinopril—ABCB1—ABC-family proteins mediated transport—ABCB6—polycystic ovary syndrome	0.00143	0.0128	CbGpPWpGaD
Lisinopril—ACE—endocrine gland—polycystic ovary syndrome	0.00141	0.0198	CbGeAlD
Lisinopril—ACE—Peptide hormone metabolism—LHB—polycystic ovary syndrome	0.0014	0.0125	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CGB5—polycystic ovary syndrome	0.00139	0.0124	CbGpPWpGaD
Lisinopril—Dehydration—Metformin—polycystic ovary syndrome	0.00139	0.0165	CcSEcCtD
Lisinopril—Lisdexamfetamine—ADRA1B—polycystic ovary syndrome	0.00137	0.162	CrCbGaD
Lisinopril—Breast disorder—Metformin—polycystic ovary syndrome	0.00135	0.016	CcSEcCtD
Lisinopril—Cramp muscle—Metformin—polycystic ovary syndrome	0.00134	0.016	CcSEcCtD
Lisinopril—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00133	0.0159	CcSEcCtD
Lisinopril—Influenza—Metformin—polycystic ovary syndrome	0.00129	0.0153	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—MANEA—polycystic ovary syndrome	0.00127	0.0113	CbGpPWpGaD
Lisinopril—Pancreatitis—Metformin—polycystic ovary syndrome	0.00126	0.015	CcSEcCtD
Lisinopril—Sweating increased—Metformin—polycystic ovary syndrome	0.00125	0.0149	CcSEcCtD
Lisinopril—Angina pectoris—Metformin—polycystic ovary syndrome	0.00125	0.0149	CcSEcCtD
Lisinopril—ACE2—Peptide hormone metabolism—LEP—polycystic ovary syndrome	0.00124	0.0111	CbGpPWpGaD
Lisinopril—Neutropenia—Metformin—polycystic ovary syndrome	0.0012	0.0143	CcSEcCtD
Lisinopril—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.0012	0.0142	CcSEcCtD
Lisinopril—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00113	0.0134	CcSEcCtD
Lisinopril—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00109	0.0129	CcSEcCtD
Lisinopril—ACE2—Peptide hormone metabolism—POMC—polycystic ovary syndrome	0.00107	0.00952	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—INS—polycystic ovary syndrome	0.00106	0.00947	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—ADAMTS7—polycystic ovary syndrome	0.00105	0.0094	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CPB2—polycystic ovary syndrome	0.00105	0.0094	CbGpPWpGaD
Lisinopril—Bradycardia—Metformin—polycystic ovary syndrome	0.00105	0.0125	CcSEcCtD
Lisinopril—Rhinitis—Metformin—polycystic ovary syndrome	0.00103	0.0123	CcSEcCtD
Lisinopril—Hepatitis—Metformin—polycystic ovary syndrome	0.00103	0.0123	CcSEcCtD
Lisinopril—ACE2—Peptide hormone metabolism—IGF1—polycystic ovary syndrome	0.00103	0.00916	CbGpPWpGaD
Lisinopril—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00102	0.0121	CcSEcCtD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—BCL11A—polycystic ovary syndrome	0.000999	0.00893	CbGpPWpGaD
Lisinopril—ABCB1—embryo—polycystic ovary syndrome	0.000965	0.0136	CbGeAlD
Lisinopril—Flushing—Metformin—polycystic ovary syndrome	0.000957	0.0114	CcSEcCtD
Lisinopril—Angiopathy—Metformin—polycystic ovary syndrome	0.000935	0.0111	CcSEcCtD
Lisinopril—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000929	0.0111	CcSEcCtD
Lisinopril—Chills—Metformin—polycystic ovary syndrome	0.000925	0.011	CcSEcCtD
Lisinopril—ACE—Peptide hormone metabolism—GHRL—polycystic ovary syndrome	0.000921	0.00823	CbGpPWpGaD
Lisinopril—Fosinopril—ACE—polycystic ovary syndrome	0.000918	0.109	CrCbGaD
Lisinopril—Erythema—Metformin—polycystic ovary syndrome	0.000897	0.0107	CcSEcCtD
Lisinopril—Malnutrition—Metformin—polycystic ovary syndrome	0.000897	0.0107	CcSEcCtD
Lisinopril—Flatulence—Metformin—polycystic ovary syndrome	0.000884	0.0105	CcSEcCtD
Lisinopril—Dysgeusia—Metformin—polycystic ovary syndrome	0.000879	0.0105	CcSEcCtD
Lisinopril—Muscle spasms—Metformin—polycystic ovary syndrome	0.000863	0.0103	CcSEcCtD
Lisinopril—ABCB1—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.000862	0.0077	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—TCF7L2—polycystic ovary syndrome	0.000857	0.00765	CbGpPWpGaD
Lisinopril—Vision blurred—Metformin—polycystic ovary syndrome	0.000846	0.0101	CcSEcCtD
Lisinopril—Tremor—Metformin—polycystic ovary syndrome	0.000841	0.01	CcSEcCtD
Lisinopril—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000833	0.00991	CcSEcCtD
Lisinopril—Malaise—Metformin—polycystic ovary syndrome	0.000809	0.00963	CcSEcCtD
Lisinopril—Syncope—Metformin—polycystic ovary syndrome	0.000805	0.00958	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—INHBB—polycystic ovary syndrome	0.000797	0.00712	CbGpPWpGaD
Lisinopril—Palpitations—Metformin—polycystic ovary syndrome	0.000793	0.00944	CcSEcCtD
Lisinopril—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000791	0.0111	CbGeAlD
Lisinopril—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000789	0.00938	CcSEcCtD
Lisinopril—Myalgia—Metformin—polycystic ovary syndrome	0.000764	0.00909	CcSEcCtD
Lisinopril—Chest pain—Metformin—polycystic ovary syndrome	0.000764	0.00909	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000759	0.00903	CcSEcCtD
Lisinopril—Discomfort—Metformin—polycystic ovary syndrome	0.000755	0.00898	CcSEcCtD
Lisinopril—Spirapril—ACE—polycystic ovary syndrome	0.00074	0.0875	CrCbGaD
Lisinopril—Oedema—Metformin—polycystic ovary syndrome	0.000732	0.00871	CcSEcCtD
Lisinopril—Infection—Metformin—polycystic ovary syndrome	0.000728	0.00866	CcSEcCtD
Lisinopril—Shock—Metformin—polycystic ovary syndrome	0.000721	0.00857	CcSEcCtD
Lisinopril—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000717	0.00853	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—RPL37A—polycystic ovary syndrome	0.000715	0.00639	CbGpPWpGaD
Lisinopril—Skin disorder—Metformin—polycystic ovary syndrome	0.000711	0.00846	CcSEcCtD
Lisinopril—Moexipril—ACE—polycystic ovary syndrome	0.00071	0.0839	CrCbGaD
Lisinopril—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000708	0.00842	CcSEcCtD
Lisinopril—ABCB1—endometrium—polycystic ovary syndrome	0.000706	0.00994	CbGeAlD
Lisinopril—Benazepril—MTHFR—polycystic ovary syndrome	0.000704	0.0832	CrCbGaD
Lisinopril—Anorexia—Metformin—polycystic ovary syndrome	0.000698	0.00831	CcSEcCtD
Lisinopril—Hypotension—Metformin—polycystic ovary syndrome	0.000684	0.00814	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000667	0.00794	CcSEcCtD
Lisinopril—Quinapril—ACE—polycystic ovary syndrome	0.00066	0.078	CrCbGaD
Lisinopril—Cilazapril—ACE—polycystic ovary syndrome	0.00066	0.078	CrCbGaD
Lisinopril—Paraesthesia—Metformin—polycystic ovary syndrome	0.000658	0.00782	CcSEcCtD
Lisinopril—Dyspnoea—Metformin—polycystic ovary syndrome	0.000653	0.00777	CcSEcCtD
Lisinopril—Somnolence—Metformin—polycystic ovary syndrome	0.000651	0.00775	CcSEcCtD
Lisinopril—ABCB1—uterus—polycystic ovary syndrome	0.000651	0.00916	CbGeAlD
Lisinopril—Dyspepsia—Metformin—polycystic ovary syndrome	0.000645	0.00767	CcSEcCtD
Lisinopril—ABCB1—pituitary gland—polycystic ovary syndrome	0.000639	0.00899	CbGeAlD
Lisinopril—Ramipril—ACE—polycystic ovary syndrome	0.000639	0.0755	CrCbGaD
Lisinopril—Trandolapril—ACE—polycystic ovary syndrome	0.000639	0.0755	CrCbGaD
Lisinopril—Decreased appetite—Metformin—polycystic ovary syndrome	0.000637	0.00758	CcSEcCtD
Lisinopril—ABCB1—adipose tissue—polycystic ovary syndrome	0.000637	0.00896	CbGeAlD
Lisinopril—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000632	0.00752	CcSEcCtD
Lisinopril—Fatigue—Metformin—polycystic ovary syndrome	0.000631	0.00751	CcSEcCtD
Lisinopril—Constipation—Metformin—polycystic ovary syndrome	0.000626	0.00745	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—CGB5—polycystic ovary syndrome	0.00062	0.00554	CbGpPWpGaD
Lisinopril—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000604	0.00718	CcSEcCtD
Lisinopril—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000599	0.00713	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—LHB—polycystic ovary syndrome	0.00059	0.00527	CbGpPWpGaD
Lisinopril—Urticaria—Metformin—polycystic ovary syndrome	0.000582	0.00692	CcSEcCtD
Lisinopril—Abdominal pain—Metformin—polycystic ovary syndrome	0.000579	0.00689	CcSEcCtD
Lisinopril—Benazepril—ACE—polycystic ovary syndrome	0.000574	0.0679	CrCbGaD
Lisinopril—ABCB1—adrenal gland—polycystic ovary syndrome	0.000571	0.00803	CbGeAlD
Lisinopril—ACE—Metabolism of proteins—MANEA—polycystic ovary syndrome	0.000567	0.00507	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—LEP—polycystic ovary syndrome	0.000554	0.00495	CbGpPWpGaD
Lisinopril—ABCB1—female gonad—polycystic ovary syndrome	0.000532	0.00749	CbGeAlD
Lisinopril—ABCB1—vagina—polycystic ovary syndrome	0.000529	0.00745	CbGeAlD
Lisinopril—ACE2—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.000527	0.00471	CbGpPWpGaD
Lisinopril—Asthenia—Metformin—polycystic ovary syndrome	0.000525	0.00625	CcSEcCtD
Lisinopril—ABCB1—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.00052	0.00465	CbGpPWpGaD
Lisinopril—Pruritus—Metformin—polycystic ovary syndrome	0.000518	0.00617	CcSEcCtD
Lisinopril—Diarrhoea—Metformin—polycystic ovary syndrome	0.000501	0.00596	CcSEcCtD
Lisinopril—ABCB1—endocrine gland—polycystic ovary syndrome	0.000495	0.00697	CbGeAlD
Lisinopril—Enalapril—ACE—polycystic ovary syndrome	0.000484	0.0573	CrCbGaD
Lisinopril—Dizziness—Metformin—polycystic ovary syndrome	0.000484	0.00576	CcSEcCtD
Lisinopril—ACE—Peptide hormone metabolism—POMC—polycystic ovary syndrome	0.000476	0.00425	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—INS—polycystic ovary syndrome	0.000473	0.00423	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—ADAMTS7—polycystic ovary syndrome	0.00047	0.0042	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CPB2—polycystic ovary syndrome	0.00047	0.0042	CbGpPWpGaD
Lisinopril—Vomiting—Metformin—polycystic ovary syndrome	0.000466	0.00554	CcSEcCtD
Lisinopril—Rash—Metformin—polycystic ovary syndrome	0.000462	0.00549	CcSEcCtD
Lisinopril—Dermatitis—Metformin—polycystic ovary syndrome	0.000461	0.00549	CcSEcCtD
Lisinopril—Headache—Metformin—polycystic ovary syndrome	0.000459	0.00546	CcSEcCtD
Lisinopril—ACE—Peptide hormone metabolism—IGF1—polycystic ovary syndrome	0.000458	0.00409	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000443	0.00396	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.000437	0.0039	CbGpPWpGaD
Lisinopril—Nausea—Metformin—polycystic ovary syndrome	0.000435	0.00518	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—GHRL—polycystic ovary syndrome	0.000389	0.00348	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—ACE—polycystic ovary syndrome	0.000377	0.00337	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	0.000362	0.00324	CbGpPWpGaD
Lisinopril—Nateglinide—PPARG—polycystic ovary syndrome	0.00036	0.0426	CrCbGaD
Lisinopril—ACE—Metabolism of proteins—INHBB—polycystic ovary syndrome	0.000356	0.00318	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB1—polycystic ovary syndrome	0.00034	0.00304	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—RPL37A—polycystic ovary syndrome	0.000319	0.00285	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000316	0.00282	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—polycystic ovary syndrome	0.000299	0.00267	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000286	0.00255	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—LHB—polycystic ovary syndrome	0.000263	0.00235	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—FOXP3—polycystic ovary syndrome	0.000261	0.00233	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—TFRC—polycystic ovary syndrome	0.000238	0.00212	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.000235	0.0021	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—LEP—polycystic ovary syndrome	0.000234	0.00209	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—POMC—polycystic ovary syndrome	0.000201	0.0018	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—INS—polycystic ovary syndrome	0.0002	0.00179	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000199	0.00178	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000197	0.00176	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.000195	0.00174	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—IGF1—polycystic ovary syndrome	0.000194	0.00173	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—GHRL—polycystic ovary syndrome	0.000174	0.00155	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	0.000162	0.00145	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00015	0.00134	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000146	0.00131	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—LEP—polycystic ovary syndrome	0.000133	0.00119	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000119	0.00107	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000111	0.00099	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000107	0.000954	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—LEP—polycystic ovary syndrome	0.000105	0.000935	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	0.000104	0.000931	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000102	0.000907	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000101	0.000906	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	9.66e-05	0.000863	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—POMC—polycystic ovary syndrome	8.99e-05	0.000803	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—INS—polycystic ovary syndrome	8.94e-05	0.000798	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—IGF1—polycystic ovary syndrome	8.64e-05	0.000772	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	8.51e-05	0.00076	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	7.89e-05	0.000705	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	7.17e-05	0.000641	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	6.72e-05	0.000601	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	6.26e-05	0.000559	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	6.21e-05	0.000555	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	5.72e-05	0.000511	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	5.72e-05	0.000511	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	5.32e-05	0.000475	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	4.69e-05	0.000419	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	4.52e-05	0.000404	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	4.52e-05	0.000404	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	4.1e-05	0.000366	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	4.03e-05	0.00036	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	3.79e-05	0.000339	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	3.75e-05	0.000335	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	3.59e-05	0.000321	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—STAR—polycystic ovary syndrome	3.43e-05	0.000306	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	3.43e-05	0.000306	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	3.06e-05	0.000274	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	3.06e-05	0.000273	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	2.92e-05	0.00026	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.88e-05	0.000257	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LHB—polycystic ovary syndrome	2.66e-05	0.000237	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	2.6e-05	0.000232	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	2.52e-05	0.000225	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	2.32e-05	0.000207	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	2.24e-05	0.0002	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	2.16e-05	0.000193	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	2.08e-05	0.000186	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	2.05e-05	0.000183	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	1.94e-05	0.000173	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.91e-05	0.00017	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.65e-05	0.000147	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.61e-05	0.000143	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	1.51e-05	0.000135	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	1.35e-05	0.00012	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	1.28e-05	0.000115	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	1.22e-05	0.000109	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	1.13e-05	0.000101	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	9.2e-06	8.22e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—POMC—polycystic ovary syndrome	9.07e-06	8.1e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—INS—polycystic ovary syndrome	9.02e-06	8.06e-05	CbGpPWpGaD
